Pfizer sells off global infusion unit to ICU for $1 billion
Pfizer’s is selling its global infusion therapy business, Hospira Infusion Systems, to ICU Medical, in a cash/stock deal worth $1 billion.
Read More
Tag: ICU
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
